Kun Ke

975 total citations
39 papers, 586 citations indexed

About

Kun Ke is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kun Ke has authored 39 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Kun Ke's work include Cancer Mechanisms and Therapy (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Kun Ke is often cited by papers focused on Cancer Mechanisms and Therapy (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Kun Ke collaborates with scholars based in China, United States and Switzerland. Kun Ke's co-authors include Xiaolong Liu, Jingfeng Liu, Naishun Liao, Yingchao Wang, Bixing Zhao, W. Chen, Zhixiong Cai, Yiping Mou, Xiaoyuan Zheng and Da Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Kun Ke

37 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Ke China 16 251 176 161 140 100 39 586
Chun-Ying Qu China 14 271 1.1× 97 0.6× 104 0.6× 152 1.1× 83 0.8× 25 563
Fa Yang China 15 341 1.4× 217 1.2× 210 1.3× 109 0.8× 84 0.8× 34 748
Jinlu Ma China 17 429 1.7× 100 0.6× 181 1.1× 283 2.0× 94 0.9× 49 855
Shuwei Chen China 20 426 1.7× 111 0.6× 202 1.3× 216 1.5× 56 0.6× 51 871
Xiaochun Zhang China 15 238 0.9× 155 0.9× 293 1.8× 99 0.7× 34 0.3× 33 621
Yamin Zhang China 13 344 1.4× 67 0.4× 139 0.9× 139 1.0× 79 0.8× 26 561
Xigan He China 12 459 1.8× 114 0.6× 125 0.8× 327 2.3× 36 0.4× 28 706
Zhenzhen Xu China 13 268 1.1× 72 0.4× 215 1.3× 181 1.3× 58 0.6× 28 575

Countries citing papers authored by Kun Ke

Since Specialization
Citations

This map shows the geographic impact of Kun Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Ke more than expected).

Fields of papers citing papers by Kun Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Ke. The network helps show where Kun Ke may publish in the future.

Co-authorship network of co-authors of Kun Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Ke. A scholar is included among the top collaborators of Kun Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Ke. Kun Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yujie, Jingyao Huang, Quan Shen, et al.. (2025). NK Cell Exosomes Alleviate PD-L1 Expression and Facilitate Tumor Immunity by Repressing PI3K-AKT-mTOR Signaling. Immunological Investigations. 54(3). 382–395. 2 indexed citations
2.
3.
Ou, Li, Kun Ke, Jianzhang Wu, et al.. (2024). Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review). International Journal of Oncology. 64(6). 14 indexed citations
4.
5.
Ke, Kun, et al.. (2023). Transthyretin promotes the invasion of combined hepatocellular cholangiocarcinoma by tumor‐associated macrophages. Cancer Reports. 6(10). e1888–e1888. 3 indexed citations
6.
7.
Ke, Kun, et al.. (2023). Increased Expression of CD74 in Atherosclerosis Associated with Inflammatory Responses of Endothelial Cells and Macrophages. Biochemical Genetics. 62(1). 294–310. 3 indexed citations
8.
Ke, Kun, et al.. (2022). A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma. Translational Cancer Research. 11(1). 99–112. 7 indexed citations
9.
Huang, Xingxing, Kun Ke, Qianru Zhu, et al.. (2022). Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer. Frontiers in Immunology. 13. 887048–887048. 36 indexed citations
10.
Wu, Zhengzhong, et al.. (2021). Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway. Cancer Cell International. 21(1). 538–538. 21 indexed citations
11.
Zheng, Hui, Yang Weizhu, Kun Ke, & Jingyao Huang. (2020). Endovascular Repair of Spontaneous Iliac Vein Rupture. Annals of Vascular Surgery. 73. 510.e25–510.e28. 5 indexed citations
12.
Zhao, Bixing, Yingchao Wang, Kun Ke, et al.. (2019). Inflammatory Micro-environment Contributes to Stemness Properties and Metastatic Potential of HCC via the NF-κB/miR-497/SALL4 Axis. Molecular Therapy — Oncolytics. 15. 79–90. 31 indexed citations
13.
Xing, Xiaohua, Ying Sun, Kun Ke, et al.. (2019). Dataset for quantitative phospho-proteomics analysis of a serial hepatoma cell lines with increasing invasion and metastasis potential. SHILAP Revista de lepidopterología. 27. 104634–104634. 1 indexed citations
14.
Zhao, Bixing, Xiaoyuan Zheng, Kun Ke, et al.. (2019). Ku80 negatively regulates the expression of OCT4 via competitive binding to SALL4 and promoting lysosomal degradation of OCT4. The International Journal of Biochemistry & Cell Biology. 118. 105664–105664. 4 indexed citations
15.
Zhao, Bixing, Yingchao Wang, Xiaoyuan Zheng, et al.. (2019). An Optogenetic Controllable T Cell System for Hepatocellular Carcinoma Immunotherapy. Theranostics. 9(7). 1837–1850. 38 indexed citations
16.
Ke, Kun, Geng Chen, Zhixiong Cai, et al.. (2018). Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification. Cancer Management and Research. Volume 10. 5291–5302. 19 indexed citations
17.
Li, Ming, Xiaomo Wu, Ju Gao, et al.. (2018). Mutations in the P10 region of procaspase-8 lead to chemotherapy resistance in acute myeloid leukemia by impairing procaspase-8 dimerization. Cell Death and Disease. 9(5). 516–516. 15 indexed citations
18.
Cai, Xinran, et al.. (2017). Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells. Current Medical Science. 37(5). 719–725. 14 indexed citations
19.
Ke, Kun, Hui Zheng, & Yang Weizhu. (2016). Is Multilayer Bare Stent Safe or Effective for the Treatment of Aortic Aneurysms? A Meta-analysis with Early and Mid-term Outcomes. Annals of Vascular Surgery. 40. 112–119. 10 indexed citations
20.
Chen, W., et al.. (2014). Combined portal vein resection in the treatment of hilar cholangiocarcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology. 40(5). 489–495. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun-Ying Qu Breakdown of academic impact, for papers by Fa Yang Breakdown of academic impact, for papers by Jinlu Ma Breakdown of academic impact, for papers by Shuwei Chen Breakdown of academic impact, for papers by Xiaochun Zhang Breakdown of academic impact, for papers by Yamin Zhang Breakdown of academic impact, for papers by Xigan He Breakdown of academic impact, for papers by Zhenzhen Xu
Rankless by CCL
2026